Milestone Scientific (NYSEAMERICAN:MLSS) Releases Earnings Results, Hits Estimates

Milestone Scientific (NYSEAMERICAN:MLSS – Get Rating) issued its quarterly earnings data on Tuesday. The medical instruments supplier reported ($0.03) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.03), Fidelity Earnings reports. Milestone Scientific had a negative return on equity of 39.43% and a negative net margin of 79.28%.

Shares of Milestone Scientific stock opened at $0.87 on Thursday. The company has a market cap of $59.26 million, a P/E ratio of -9.67 and a beta of 1.34. Milestone Scientific has a 52 week low of $0.75 and a 52 week high of $3.00.

Separately, Maxim Group decreased their target price on shares of Milestone Scientific from $6.00 to $4.00 in a research note on Monday, April 4th.

Several hedge funds have recently bought and sold shares of MLSS. Jane Street Group LLC bought a new stake in Milestone Scientific during the 1st quarter valued at about $35,000. Royal Bank of Canada purchased a new stake in shares of Milestone Scientific during the first quarter valued at approximately $30,000. Sequoia Financial Advisors LLC bought a new stake in shares of Milestone Scientific during the first quarter valued at approximately $86,000. Barclays PLC raised its holdings in Milestone Scientific by 475.6% in the 4th quarter. Barclays PLC now owns 40,842 shares of the medical instruments supplier’s stock worth $84,000 after acquiring an additional 33,747 shares during the last quarter. Finally, BlackRock Inc. lifted its position in Milestone Scientific by 6.1% in the 4th quarter. BlackRock Inc. now owns 210,503 shares of the medical instruments supplier’s stock valued at $433,000 after acquiring an additional 12,151 shares in the last quarter. Hedge funds and other institutional investors own 8.82% of the company’s stock.

Milestone Scientific Company Profile (Get Rating)

Milestone Scientific Inc designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic.

Featured Articles